Items where contributor is "Goig, Galo"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2022 | 2021


Cox, H. and Goig, G. A. and Salaam-Dreyer, Z. and Dippenaar, A. and Reuter, A. and Mohr-Holland, E. and Daniels, J. and Cudahy, P. G. T. and Nicol, M. P. and Borrell, S. and Reinhard, M. and Doetsch, A. and Beisel, C. and Gagneux, S. and Warren, R. M. and Furin, J.. (2022) Whole genome sequencing has the potential to improve treatment for rifampicin-resistant tuberculosis in high burden settings: a retrospective cohort study. Journal of clinical microbiology, 60 (3). e0236221.

Van Rie, A. and Walker, T. and de Jong, B. and Rupasinghe, P. and Riviere, E. and Dartois, V. and Sonnenkalb, L. and Machado, D. and Gagneux, S. and Supply, P. and Dreyer, V. and Niemann, S. and Goig, G. and Meehan, C. and Tagliani, E. and Cirillo, D. M.. (2022) Balancing access to BPaLM regimens and risk of resistance. The Lancet infectious diseases, S1473-3099 (22). 00543-00546.


Cox, H. and Salaam-Dreyer, Z. and Goig, G. A. and Nicol, M. P. and Menardo, F. and Dippenaar, A. and Mohr-Holland, E. and Daniels, J. and Cudahy, P. G. T. and Borrell, S. and Reinhard, M. and Dötsch, A. and Beisel, C. and Reuter, A. and Furin, J. and Gagneux, S. and Warren, R. M.. (2021) Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study. Lancet Microbe, 2 (11). e584-e593.

López, M. G. and Chiner-Oms, A. and García de Viedma, D. and Ruiz-Rodriguez, P. and Bracho, M. A. and Cancino-Muñoz, I. and D'Auria, G. and de Marco, G. and García-González, N. and Goig, G. A. and Gómez-Navarro, I. and Jiménez-Serrano, S. and Martinez-Priego, L. and Ruiz-Hueso, P. and Ruiz-Roldán, L. and Torres-Puente, M. and Alberola, J. and Albert, E. and Aranzamendi Zaldumbide, M. and Bea-Escudero, M. P. and Boga, J. A. and Bordoy, A. E. and Canut-Blasco, A. and Carvajal, A. and Cilla Eguiluz, G. and Cordón Rodríguez, M. L. and Costa-Alcalde, J. J. and de Toro, M. and de Toro Peinado, I. and Del Pozo, J. L. and Duchêne, S. and Fernández-Pinero, J. and Fuster Escrivá, B. and Gimeno Cardona, C. and González Galán, V. and Gonzalo Jiménez, N. and Hernáez Crespo, S. and Herranz, M. and Lepe, J. A. and López-Causapé, C. and López-Hontangas, J. L. and Martín, V. and Martró, E. and Milagro Beamonte, A. and Montes Ros, M. and Moreno-Muñoz, R. and Navarro, D. and Navarro-Marí, J. M. and Not, A. and Oliver, A. and Palop-Borrás, B. and Parra Grande, M. and Pedrosa-Corral, I. and Pérez González, M. C. and Pérez-Lago, L. and Pérez-Ruiz, M. and Pineiro Vazquez, L. and Rabella, N. and Rezusta, A. and Robles Fonseca, L. and Rodríguez-Villodres, A. and Sanbonmatsu-Gámez, S. and Sicilia, J. and Soriano, A. and Tirado Balaguer, M. D. and Torres, I. and Tristancho, A. and Marimón, J. M. and SeqCovid-Spain Consortium, and Coscolla, M. and González-Candelas, F. and Comas, I.. (2021) The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant. Nat Genet, 53 (10). pp. 1405-1414.

Mariner-Llicer, C. and Goig, G. A. and Zaragoza-Infante, L. and Torres-Puente, M. and Villamayor, L. and Navarro, D. and Borras, R. and Chiner-Oms, A. and Comas, I.. (2021) Accuracy of an amplicon-sequencing nanopore approach to identify variants in tuberculosis drug-resistance-associated genes. Microb Genom, 7 (12). 00074.